Literature DB >> 27506373

Expediting Viral Therapies For Cancers To the Clinic.

Yuman Fong.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27506373      PMCID： PMC5088752          DOI： 10.1038/mt.2016.128

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Oncolytic Treatment for Cancer Recommended for Approval.

Authors:  Yuman Fong
Journal:  Mol Ther       Date:  2015-07       Impact factor: 11.454

2.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

3.  Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.

Authors:  Manfred Westphal; Seppo Ylä-Herttuala; John Martin; Peter Warnke; Philippe Menei; David Eckland; Judith Kinley; Richard Kay; Zvi Ram
Journal:  Lancet Oncol       Date:  2013-07-12       Impact factor: 41.316

4.  Experimental therapy of human glioma by means of a genetically engineered virus mutant.

Authors:  R L Martuza; A Malick; J M Markert; K L Ruffner; D M Coen
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

5.  Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Authors:  Timothy F Cloughesy; Joseph Landolfi; Daniel J Hogan; Stephen Bloomfield; Bob Carter; Clark C Chen; J Bradley Elder; Steven N Kalkanis; Santosh Kesari; Albert Lai; Ian Y Lee; Linda M Liau; Tom Mikkelsen; Phioanh Leia Nghiemphu; David Piccioni; Tobias Walbert; Alice Chu; Asha Das; Oscar R Diago; Dawn Gammon; Harry E Gruber; Michelle Hanna; Douglas J Jolly; Noriyuki Kasahara; David McCarthy; Leah Mitchell; Derek Ostertag; Joan M Robbins; Maria Rodriguez-Aguirre; Michael A Vogelbaum
Journal:  Sci Transl Med       Date:  2016-06-01       Impact factor: 17.956
  5 in total
  1 in total

1.  In situ cancer vaccination using lipidoid nanoparticles.

Authors:  Jinjin Chen; Min Qiu; Zhongfeng Ye; Thomas Nyalile; Yamin Li; Zachary Glass; Xuewei Zhao; Liu Yang; Jianzhu Chen; Qiaobing Xu
Journal:  Sci Adv       Date:  2021-05-05       Impact factor: 14.136
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.